DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tqr8lz/prostate_cancer) has announced the addition of the "Prostate Cancer Treatment Drugs Markets in China: Updated 2014 Report" report to their offering.

China's demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented.

Major producers in China are profiled. A selection of these companies can be seen in the 'Companies Mentioned' tab. The full list can be viewed upon purchase of the report.

Key Topics Covered:

I.INTRODUCTION

II.BUSINESS ENVIRONMENT

III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

IV. PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Overview

Demand of Prostate Cancer Treatment Drugs by Region

Prostate Cancer Treatment Drugs Sales Volume

Bicalutamide Sales volume and market share

Flutamide Sales volume and market share

Cyproterone Acetate Sales volume and market share

Megestrol Acetate Sales volume and market share

Triptorelin Acetate Sales volume and market share

Goserelin Acetate Sales volume and market share

Leuprorelin Acetate Sales volume and market share

Estramustine disodium phosphate Sales volume and market share

Docetaxel Sales volume and market share

Other Prostate Cancer Treatment Drugs Sales volume and market share

Prostate Cancer Treatment Drugs Imports

Pricing Trends

V. PROSTATE CANCER TREATMENT DRUGS MARKET OUTLOOK

Prostate Cancer Treatment Drugs Markets Outlook Overview

Government Regulations

Health Care Insurance Industry Overview

Health Care Industry Trends

Hospitals and Hospital Beds

Physicians and Physician Visits

VI. MARKETING STRATEGIES

Distribution System in China

China's Distribution System

Prostate Cancer Treatment Drugs Distribution Channels

Transportation and Freight Infrastructure

Communications

China's Market Entry

Licensing

Franchising

E-commerce

Trading Companies and Local Agents

Representative Offices and Chinese Subsidiaries

Wholly Foreign Owned Enterprises

VII. PROSTATE CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Companies Mentioned:

• Hangzhou Sinopep Pharmaceutical
• Bam Biotech

For more information visit http://www.researchandmarkets.com/research/tqr8lz/prostate_cancer